We use cookies to understand how you use our site and to improve the overall user experience. This includes personalizing content and advertising. Read our Privacy Policy
CAT No: N1101
CAS No: 3106-85-2
Synonyms/Alias: spaglumic acid;Isospaglumic acid;3106-85-2;NAAG;N-Acetyl-Asp-Glu;N-Acetylaspartylglutamic acid;N-acetylaspartylglutamate;Acido isospaglumico;Acide isospaglumique;NAAGA;Isospaglumic acid [INN];N-Acetyl-L-aspartyl-L-glutamic acid;Acidum isospaglumicum;1W8M12WXYL;Acide isospaglumique [French];Acido isospaglumico [Spanish];Acidum isospaglumicum [Latin];(S)-2-((S)-2-Acetamido-3-carboxypropanamido)pentanedioic acid;L-Glutamic acid, N-acetyl-L-alpha-aspartyl-;MFCD00076652;(2S)-2-[[(2S)-2-acetamido-3-carboxypropanoyl]amino]pentanedioic acid;N-Acetyl-1-aspartylglutamic acid;CHEBI:73688;N-acetylaspartylglutamate (NAAG);ISOSPAGLUMIC ACID [MART.];N-(N-Acetyl-L-alpha-aspartyl)-L-glutamic acid;ISOSPAGLUMIC ACID [WHO-DD];N-acetyl-L-alpha-aspartyl-L-glutamic acid;Acidum isospaglumicum (Latin);Ac-Asp-Glu-OH;N-(N-ACETYL-L-.ALPHA.-ASPARTYL)-L-GLUTAMIC ACID;ISOSPAGLUMIC ACID (MART.);NAAGA sodium salt;N-acetyl-1-Asp-Glu;SR-01000597665;UNII-1W8M12WXYL;spaglumic-acid;N-Acetyl-alpha-aspartylglutamic acid;N-acetyl-aspartyl-glutamic acid;(2S)-2-(((2S)-2-acetamido-3-carboxypropanoyl)amino)pentanedioic acid;a-Spaglumic acid;Ac-Asp-Glu;Zy15109;alpha-Spaglumic acid;N-acetyl-L-alpha-aspartylglutamic acid;ZY15106;Spectrum_000399;Tocris-0391;L-Glutamic acid, N-acetyl-L-a-aspartyl-;ZY 15106;N-acetyl-L-Asp-L-Glu;Prestwick0_001091;Prestwick1_001091;Prestwick2_001091;Spectrum2_001571;Spectrum3_000759;Spectrum4_000873;Spectrum5_001840;N-Ac-D-E;[3H]NAAG;BSPBio_002378;BSPBio_003230;KBioGR_001565;KBioSS_000879;2-[(2-acetamido-3-carboxy-1-oxopropyl)amino]pentanedioic acid;DivK1c_000662;SCHEMBL288514;SPECTRUM1503630;SPBio_001502;SPBio_003051;GTPL1405;Acetyl-a-L-aspartylglutamic acid;CHEMBL1329032;DTXSID3091535;Isospaglumic acid;Spaglumic Acid;n-acetyl-a-aspartylglutamic acid;BDBM17658;HMS502B04;KBio1_000662;KBio2_000879;KBio2_003447;KBio2_006015;KBio3_001598;NINDS_000662;HMS1571K04;HMS3411I03;HMS3675I03;N-(N-Acetylaspartyl)glutamic acid;Pharmakon1600-01503630;Acetyl-alpha-L-aspartylglutamic acid;CCG-38888;NSC758468;(2S)-2-[[(2S)-2-acetamido-4-hydroxy-4-oxobutanoyl]amino]pentanedioic acid;AKOS024457865;FA05316;N-Acetyl-a-L-aspartyl-L-glutamic acid;SDCCGMLS-0066696.P001;IDI1_000662;NCGC00016651-01;NCGC00016651-02;NCGC00024569-01;NCGC00024569-02;AS-76948;N-Acetyl-alpha-L-aspartyl-L-glutamic acid;SBI-0052840.P002;HY-100921;CS-0020591;NS00007578;C15544;AB00053333_02;Q2394106;SR-01000597665-1;SR-01000597665-2;BRD-K68405354-001-06-4;BRD-K68405354-001-07-2;(2S)-2-[(3S)-3-acetamido-3-formamidopropanoic acid]pentanedioic acid;635-744-0;
Quick InquiryCustom Peptide SynthesisPeptide Library Construction and Screening
Powerful screening tools in biological and chemical research
M.F/Formula | C11H16N2O8 |
M.W/Mr. | 304.25 |
Sequence | One Letter Code:DE Three Letter Code:Ac-Asp-Glu-OH |
Source# | Synthetic |
InChI | InChI=1S/C11H16N2O8/c1-5(14)12-7(4-9(17)18)10(19)13-6(11(20)21)2-3-8(15)16/h6-7H,2-4H2,1H3,(H,12,14)(H,13,19)(H,15,16)(H,17,18)(H,20,21)/t6-,7-/m0/s1 |
InChI Key | OPVPGKGADVGKTG-BQBZGAKWSA-N |
2. High fat diet and GLP-1 drugs induce pancreatic injury in mice
3. TMEM16F and dynamins control expansive plasma membrane reservoirs
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at info@creative-peptides.com. We will endeavor to provide highly satisfying products and services.